SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-008936 to Molecular Templates, Inc. (MTEM) (CIK 0001183765)

Molecular Templates, Inc. (MTEM) (CIK 0001183765)
Date: Aug. 16, 2023 · CIK: 0001183765 · Accession: 0000000000-23-008936

AI Filing Summary & Sentiment

File numbers found in text: 333-273864

Date
August 16, 2023
Author
Not clearly detected
Form
UPLOAD
Company
Molecular Templates, Inc. (MTEM) (CIK 0001183765)

Letter

United States securities and exchange commission logo August 16, 2023 Eric E. Poma, Ph.D. Chief Executive Officer Molecular Templates, Inc. 9301 Amberglen Blvd, Suite 100 Austin, TX 78729 Re:Molecular Templates, Inc. Registration Statement on Form S-3 Filed August 10, 2023 File No. 333-273864 Dear Eric E. Poma: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Melanie Ruthrauff Levy, Esq.

Show Raw Text
United States securities and exchange commission logo
August 16, 2023
Eric E. Poma, Ph.D.
Chief Executive Officer
Molecular Templates, Inc.
9301 Amberglen Blvd, Suite 100
Austin, TX 78729
Re:Molecular Templates, Inc.
Registration Statement on Form S-3
Filed August 10, 2023
File No. 333-273864
Dear Eric E. Poma:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Melanie Ruthrauff Levy, Esq.